Analyst Ratings for Legend Biotech
In the past quarter, analysts have shared their diverse perspectives on Legend Biotech (NASDAQ: LEGN), totaling 4 ratings. These recent ratings consist of 1 Bullish, 2 Somewhat Bullish, 1 Indifferent, and no Bearish ratings. There have been no new ratings in the last month, signaling a steady forecast. The average price target for Legend Biotech over the next year is $82.75, with a high estimate of $94.00 and a low estimate of $65.00. This average target has decreased by 11.02% compared to the previous target of $93.00.
Recent Analyst Actions
Leonid Timashev from RBC Capital upholds an Outperform rating with a price target of $85.00.
Gena Wang at Barclays upgraded the rating to Overweight with a price target of $94.00, up from the previous $93.00.
Mitchell Kapoor from HC Wainwright & Co. maintains a Buy rating with a price target of $87.00.
George Farmer at Scotiabank announced a Sector Perform rating with a price target of $65.00.
Analysts adjust their recommendations based on market conditions and company performance, demonstrating changes by maintaining, increasing, or decreasing their position on Legend Biotech.
LEGN Stock Price Analysis: Potential Growth and Volatility on March 7, 2024
On March 7, 2024, LEGN stock closed at $64.22, a $0.44 increase from the previous close, representing a 0.69% rise. LEGN is trading below its 200-day moving average, indicating potential resistance. The recent price increase may signal investor interest. LEGN remained unchanged in after-hours trading, suggesting stability. The stock’s performance on March 7, 2024, indicates volatility and potential growth. Investors should monitor closely for continued positive momentum.
LEGN Stock Shows Promising Performance with Significant Revenue Growth on March 7, 2024
On March 7, 2024, LEGN stock showed promising performance with significant increases in total revenue, net income, and earnings per share. According to data from CNN Money, the company reported a total revenue of $117.00 million for the past year, marking a 70.0% increase compared to the previous year. In the third quarter alone, total revenue reached $96.01 million, showing a 30.93% increase from the previous quarter.
Despite the positive revenue growth, LEGN reported a net income of -$446.35 million for the past year, reflecting a 10.6% decrease compared to the previous year. However, in the third quarter, the company managed to reduce its net loss to -$62.21 million, representing a significant 68.76% increase from the previous quarter.
Earnings per share also saw improvements, with a reported EPS of -$2.81 for the past year, showing a 2.05% increase compared to the previous year. In the third quarter, EPS reached -$0.34, marking a substantial 69.88% increase from the previous quarter.
Overall, LEGN stock demonstrated strong financial performance on March 7, 2024, with notable increases in total revenue, net income, and earnings per share. Investors may view these positive results as a sign of the company’s growth potential and future profitability.
